Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.2.1.36 (
hyaluronidase
)
4,606
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Determination of modification degree in BDDE-modified hyaluronic acid (HA) hydrogel is of particular interest. In this paper, three crosslinking parameters (degree of total modification, t-
MOD
; degree of cross-link modification, c-
MOD
; degree of pendent modification, p-
MOD
) are defined and determined by quantification of the modified fragments in hydrogel digestion by size exclusion chromatography combined with mass spectrometry (SEC-MS). The digestion products of a novel
hyaluronidase
HAase-B produced by Bacillus sp. A50 are studied and only a few modified fragments are identified by (1)H NMR and MS. As a result, Three HA hydrogels prepared in lab have different t-
MOD
, c-
MOD
and p-
MOD
, but the ratio of c-
MOD
to p-
MOD
result in the almost same value of 75%. Hydrogel products from Q-Med have nearly same t-
MOD
about 0.8% and c-
MOD
about 0.1%, the ratio of c-
MOD
to p-
MOD
is about 13%. Hydrogels from ANTEIS S.A all have much higher t-
MOD
values, the ratio of c-
MOD
and p-
MOD
is about 8%.
...
PMID:Determination of modification degree in BDDE-modified hyaluronic acid hydrogel by SEC/MS. 2625 80